Pfizer units settle HRT case in Reno; GSK workers in U.K. plan strike vote;

@FiercePharma: Novartis to plow $500M into Russia. Item | Follow @FiercePharma

> Wyeth and Upjohn, both owned by Pfizer, have agreed to settle with two women who had sued claiming that hormone replacement drugs had caused their breast cancer. Report

> Sanofi-Aventis buyout target Genzyme is once again touting its prospective multiple sclerosis treatment to investors, but analysts still don't expect the drug to reach the lofty $3 billion to $3.5 billion in sales Genzyme predicts. News

> About 200 workers at GlaxoSmithKline Consumer Healthcare's Coleford, England, site are to be balloted over possible strike action because of a disagreement over a recent pay offer. Item

> Novartis, Bayer and Boehringer Ingelheim are among drugmakers vying for animal-health assets being sold by Sanofi-Aventis SA and Merck, Financial Times Deutschland reported, without saying where it got the information. Story

> Novartis plans to move the headquarters of its infectious disease unit to Emeryville, California, from Cambridge, Massachusetts. Article

> Aspen PharmaCare, 20 percent owned by GlaxoSmithKline, has won more than 40 percent of the country's two-year, $630 million antiretroviral drug tender. Report

> A Ranbaxy Laboratories joint venture has been awarded a two-year contract to supply antiretrovirals (ARV) to the South African government. News

Biotech News

@FierceBiotech:  BMS, Oncolys ink HIV pact. Story | Follow @FierceBiotech

 @JohnCFierce: Wonder what big pharma thinks about China's thoughts on slashing drug prices unilaterally. Emerging market or mayhem? Report | Follow @JohnCFierce

> Incyte shares jump on positive PhIII cancer data. Story 

> Termeer: "It can't go on forever." News

> Biogen scoops up CNS programs in $427M acquisition deal. Article 

> AZ writes off crucial motavizumab program and $445M. Report

 Biotech Research News

> Why is the NDM-1 superbug is so hard to kill? News

> Stumped researchers examine new strategies against Alzheimer's. Article 

> Next-gen tech reduces gene sequencing to a simple, cheap procedure. Item 

> Collins continues to see promise in use of genomic information. Report

Manufacturing News

> Turnabout in plastic vs. wood pallet war. Article

> Agencies team to bust fake Viagra peddler. News 

> Catalent fined in worker dermatitis cases. Story 

> Gunmen enjoy walk-in warehouse theft, quick arrest. Item

And Finally... A mouse virus linked to chronic fatigue syndrome may not be the cause of the disease, according to four studies. Item

Suggested Articles

Johnson & Johnson and Bayer’s Xarelto is working to reverse a sales slide, and a new indication could help.

AZ's FluMist will be dramatically limited in the U.S. this flu season because of production problems, a spokeswoman said.

To get its $12 billion opioid deal off the ground, Purdue Pharma pushed for a stay on thousands of lawsuits against it. Last week, a judge signed off.